Short-Term Changes in Intraocular Pressure After Intravitreal Injection of Bevacizumab for the Treatment of Retinopathy of Prematurity.
Shumpei ObataTomoaki HigashiyamaTaku ImamuraMasashi KakinokiTakahide YanagiYoshihiro MaruoMasahito OhjiPublished in: Clinical ophthalmology (Auckland, N.Z.) (2019)
Intraocular pressure elevation after intravitreal injection of bevacizumab for neonatal infants may be mild, so there may be a limited risk due to intraocular pressure after intraocular injection of bevacizumab for retinopathy of prematurity.